| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/08/1998 | EP0833846A1 Human g-protein coupled receptor (hetgq23) |
| 04/08/1998 | EP0833844A1 SINGLE CHAIN ANALOGS OF THE TGF-$g(b) SUPERFAMILY (MORPHONS) |
| 04/08/1998 | EP0833841A1 New family of linear antimicrobial peptides from hagfish intestine |
| 04/08/1998 | EP0833840A1 Hypoxia inducible factor-1 and method of use |
| 04/08/1998 | EP0833835A1 Obesity protein intermediates and their preparation and use |
| 04/08/1998 | EP0833834A1 Dna sequence and encoded mammary-specific breast cancer protein |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833668A1 Inhibition of hepatitis b replication |
| 04/08/1998 | EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 04/08/1998 | EP0833661A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/08/1998 | EP0833660A1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0833658A1 Inhibin compositions and methods of enhancing production performance |
| 04/08/1998 | EP0833656A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0618966B1 Method for preparing double stranded rna, and use thereof |
| 04/08/1998 | EP0256092B1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| 04/08/1998 | CN1178555A Gene recombinant |
| 04/08/1998 | CN1178554A chemically modified interperon |
| 04/08/1998 | CN1178553A Recombinant DNA prepared by intergrating DNA that codes for myosin heavy-chtain SMI isoform protein into vector DNA, and arteriosclerosis remedy both containing the recombinant DNA |
| 04/08/1998 | CN1178551A Ensyme with aminopeptidase activity |
| 04/08/1998 | CN1178534A Isolated nucleic acid molecules as members of the Mage-Xp family and uses thereof |
| 04/08/1998 | CN1178472A Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 04/08/1998 | CN1178245A Production of trans-4-hydroxy-L-proline |
| 04/08/1998 | CN1178244A Preparation of reorganized human saccharified urokinasen |
| 04/08/1998 | CN1178243A Human gene P53BP3 interacting with anti-cancer gene P53 |
| 04/08/1998 | CN1178242A Specific antibody Anti 5-7 for pseudohypertrophic muscular dystrophy |
| 04/07/1998 | US5736629 Herbicide resistant rice |
| 04/07/1998 | US5736627 Virus resistant plants having coat protein |
| 04/07/1998 | US5736524 Polynucleotide tuberculosis vaccine |
| 04/07/1998 | US5736521 Administering amino acid compound |
| 04/07/1998 | US5736516 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein protein |
| 04/07/1998 | US5736514 Bacillus strain and harmful organism controlling agents |
| 04/07/1998 | US5736513 Insecticide |
| 04/07/1998 | US5736499 Mutant A-amylase |
| 04/07/1998 | US5736400 Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers |
| 04/07/1998 | US5736395 Transforming cells in mammal by contacting with complexes comprising an expression cassette and a nitrogen-containing amphiphile |
| 04/07/1998 | US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736390 BCRF1 proteins as inhibitors of interferon-γ |
| 04/07/1998 | US5736389 Treatment of colorectal cancer |
| 04/07/1998 | US5736388 Genetic engineering |
| 04/07/1998 | US5736387 Envelope fusion vectors for use in gene delivery |
| 04/07/1998 | US5736384 Thermostable xylanase |
| 04/07/1998 | US5736383 Exposing yeast cells to mutagenizing conditions and culturing in a nitrogen deficient medium containing nystatin for selective killing of cells which are not auxotropic for adenine |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736379 DNA sequences expressing mammalian α1 antitrypsin |
| 04/07/1998 | US5736375 Dna molecule |
| 04/07/1998 | US5736374 Increased production of β-galactosidase in aspergillus oryzae |
| 04/07/1998 | US5736369 Genetic engineering |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736367 Vectors and prokaryotes which autocatalytically delete antibiotic resistance |
| 04/07/1998 | US5736365 Using a single pair of primers and appending an adapter sequence to the targets; simultaneous identification of mycobacterium tuberculosis and providing a screen for all clinically relevant species |
| 04/07/1998 | US5736363 Insulin-like growth factor; polypeptide |
| 04/07/1998 | US5736362 An isolated nucleic acid comprising nucleotide sequence encoding amino acid sequence 25-276 of a rye grass pollen protein |
| 04/07/1998 | US5736361 Production of gonorrheal PI proteins |
| 04/07/1998 | US5736360 Nucleic acid comprising modified murine leukemia virus long terminal repeat |
| 04/07/1998 | US5736359 Vector containing dominant activator sequence and heterologous gene linked to promoter, for transfection of mammalian cells to obtain expression of desired gene |
| 04/07/1998 | US5736358 Dna molecule; malaria |
| 04/07/1998 | US5736356 Transglutaminase originating from Crassostrea gigas |
| 04/07/1998 | US5736347 Nucleic acids of Rochalimaea henselae and methods and compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infection |
| 04/07/1998 | US5736345 Incubation and culturing |
| 04/07/1998 | US5736341 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736338 Method of diagnosing Neoplastic disease by detecting increased expression of human MDM2 protein |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736333 Internal reference molecule comprising first and second fluorophores joined by nonhybridizing backbone connector which permits the transfer of energy from one to the other |
| 04/07/1998 | US5736332 Hybridizing labeled sample to complementary oligonucleotide probe immobilized on transponder, decoding transponder data |
| 04/07/1998 | US5736331 Method for identifying nucleic acids encoding c-fos promoter activating proteins |
| 04/07/1998 | US5736329 Method for testing for the presence of Alzheimer's Disease |
| 04/07/1998 | US5736327 Discontinuous probe design using hybritope mapping |
| 04/07/1998 | US5736323 Hybridizing a pair of primers, amplifying and detecting an intron 16; diabetes; hypertension |
| 04/07/1998 | US5736319 Analyzing for absence of glycoproteins x or i in pseudorabies virus antigen-containing serum of animals (i.e. swine) to distinguish between vaccination and virulent infections |
| 04/07/1998 | US5736316 HBV capture and amplifiers probes for use in solution phase sandwich hybridization assays |
| 04/07/1998 | US5736315 Methods and compositions for detecting anti-hepatitis E virus activity |
| 04/07/1998 | US5736294 Genetic engineering |
| 04/07/1998 | US5736149 Allergenic proteins and peptides from johnson grass pollen |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736135 Method for making variant secreted proteins with altered properties |
| 04/07/1998 | US5736134 Tissue plasminogen activator variants |
| 04/07/1998 | US5736131 Hybrid toxin |
| 04/07/1998 | US5736106 Thermal cycling reaction apparatus and reactor therefor |
| 04/07/1998 | US5735078 Method of producing intergeneric or interspecific hybrids by ion beam irradiation |
| 04/07/1998 | CA1339799C Controlled excision |
| 04/02/1998 | WO1998013527A2 Compositions and methods for enhancing hybridization specificity |
| 04/02/1998 | WO1998013526A1 Three component chimeric antisense oligonucleotides |
| 04/02/1998 | WO1998013523A1 Method of sequencing dna |
| 04/02/1998 | WO1998013522A1 The use of modular oligonucleotides as probes or primers in nucleic acid based assay |
| 04/02/1998 | WO1998013514A1 Method for determining ion channel activity of a substance |
| 04/02/1998 | WO1998013513A2 Methods and compositions for identifying receptor effectors |
| 04/02/1998 | WO1998013511A1 Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic togavirus vectors |
| 04/02/1998 | WO1998013510A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | WO1998013509A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | WO1998013508A1 Method of targeting malignant cells using an e2f responsive promoter |
| 04/02/1998 | WO1998013507A1 Hex ii tumor-specific promoter and uses thereof in cancer therapy |